Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1283658-71-8
1415800-34-8
1621616-14-5
1807503-87-2
1807521-04-5
2055014-77-0
2093152-84-0 | N-(Mal-PEG6)-N-bis(PEG7-TCO) | AA019E7Y | MFCD30723286
2183440-27-7 | endo-BCN-PEG12-acid | AA019ECM | MFCD31692214
2183473-43-8 | BDP 630/650 hydrazide | AA019EGF | MFCD31580095
1266384-47-7 | N-(4-chloro-3-methylphenyl)-4-methyl-benzenesulfonamide | AA019EJK | MFCD31652796
1715249-34-5 | 4-bromo-N-(3,5-difluorophenyl)-2-fluorobenzenesulfonamide | AA019EMK | MFCD27975686
98789-95-8 | 4-Decylcyclohexanone | AA019EPV | MFCD25323924
245487-45-0 | 2,2,2-Trifluoro-1-(piperazin-1-yl)ethanonehydrochloride | AA019ESY | MFCD22421756
207737-64-2 | 1-(4-(benzyloxy)phenyl)-4-methylpentan-3-one | AA019EVR | MFCD31555313
90947-00-5 | (E)-5-(4-IODOBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE | AA019EZ5 | MFCD00449708
886370-54-3 | 1-(2-Chlorophenyl)-2,2,2-trifluoroethanamine | AA019FTZ | MFCD07374772